drugset / Trial / NCT07181265

Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects

NCT07181265

Phase 1 Not yet recruiting 48 enrolled Jemincare
Non-randomizedSequentialOpen-labelBasic science

Summary

This is a open-label, non-randomized, multiple oral dosings, three-period, drug-drug interaction study of JMKX003142 tablet, Amiodarone Hydrochloride Tablets and Febuxostat Tablets in Chinese healthy adult subjects

Timeline

Start
2025-10-30
Primary completion
2026-04-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 400 mg Oral
Subject Febuxostat Small molecule 40 mg Oral